PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (FIOCRUZ), 50670-420 Recife, PE, Brazil; Graduate Program in Applied Cellular and Molecular Biology, University of Pernambuco (UPE), 50100-130 Recife, PE, Brazil. Electronic address: fabio.formiga@fiocruz.br.\', \'Department of Chemistry, University of Miami, 1301 Memorial Drive, Coral Gables, FL 33146, USA.\', \'Institute of Biological Sciences, University of Pernambuco (UPE), 50100-130 Recife, PE, Brazil.\', \'Laboratory of Inflammation and Biomarkers, Gonçalo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), 40296-710 Salvador, BA, Brazil.\', \'Bioactive Compounds Synthesis Laboratory, Department of Chemistry, Federal Rural University of Pernambuco (UFRPE), 52171-900 Recife, PE, Brazil.\', \'Department of Virology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (FIOCRUZ), 50670-420 Recife, PE, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0168-3659(20)30580-010.1016/j.jconrel.2020.10.009
?:hasPublicationType
?:journal
  • Journal of controlled release : official journal of the Controlled Release Society
is ?:pmid of
?:pmid
?:pmid
  • 33038449
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Ivermectin: an award-winning drug with expected antiviral activity against COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all